MENU
TRUH
ETF ticker: NASDAQ
PRICE
CHANGE
NET ASSETS

TRUH stock forecast, quote, news & analysis

The investment seeks long-term capital appreciation... Show more

Category: #Health
Interact to see
Advertisement
A.I.Advisor
published price charts
TRUH
Daily Signal:
Gain/Loss:
A.I.Advisor
a Summary for TRUH with price predictions
Oct 14, 2026

TRUH's MACD Histogram just turned positive

The Moving Average Convergence Divergence (MACD) for TRUH turned positive on October 09, 2026. Looking at past instances where TRUH's MACD turned positive, the stock continued to rise in 4 of 4 cases over the following month. The odds of a continued upward trend are 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 14, 2026. You may want to consider a long position or call options on TRUH as a result. In 6 of 7 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 86%.

Following a +2.27% 3-day Advance, the price is estimated to grow further. Considering data from situations where TRUH advanced for three days, in 15 of 21 cases, the price rose further within the following month. The odds of a continued upward trend are 71%.

The Aroon Indicator entered an Uptrend today. In 35 of 40 cases where TRUH Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 88%.

Bearish Trend Analysis

The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where TRUH declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 58%.

TRUH broke above its upper Bollinger Band on October 14, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Eli Lilly & Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), ABBVIE (NYSE:ABBV), Merck & Co (NYSE:MRK), Unitedhealth Group (NYSE:UNH), Amgen (NASDAQ:AMGN), Gilead Sciences (NASDAQ:GILD), Abbott Laboratories (NYSE:ABT), Pfizer (NYSE:PFE), Intuitive Surgical (NASDAQ:ISRG).

Industry description

The investment seeks long-term capital appreciation. The fund is an actively managed exchange-traded fund that seeks to achieve its investment objective by investing, under normal market circumstances, at least 80% of its total assets in equity securities of healthcare-related companies or instruments that provide exposure to healthcare-related companies as determined by the Adviser. For purposes of this policy, the term “assets” means net assets plus the amount of any borrowings for investment purposes. The fund is non-diversified.

Market Cap

The average market capitalization across the VanEck Healthcare TruSector ETF (TRUH) ETF is 171.22B. The market cap for tickers in the group ranges from 9.23B to 1.06T. LLY holds the highest valuation in this group at 1.06T. The lowest valued company is PODD at 9.23B.

High and low price notable news

The average weekly price growth across all stocks in the VanEck Healthcare TruSector ETF (TRUH) ETF was 20%. For the same ETF, the average monthly price growth was 64%, and the average quarterly price growth was 340%. MRNA experienced the highest price growth at 15%, while JNJ experienced the biggest fall at -2%.

Volume

The average weekly volume growth across all stocks in the VanEck Healthcare TruSector ETF (TRUH) ETF was 15%. For the same stocks of the ETF, the average monthly volume growth was 44% and the average quarterly volume growth was -6%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 33
P/E Growth Rating: 39
Price Growth Rating: 31
SMR Rating: 56
Profit Risk Rating: 66
Seasonality Score: 28 (-100 ... +100)
TRUH's MACD Histogram just turned positive